Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: A multicenter case series

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Tan, Dingyu ^a   Zhu, Huadong ^a   Fu, Yangyang ^a   Tong, Fei ^b   Yao, Dongqi ^b   Walline, Joseph ^c   Xu, Jun ^a   Yu, Xuezhong ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; GANCICLOVIR; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; OSELTAMIVIR; RIBAVIRIN; ANTIVIRUS AGENT; VIRUS DNA;

ACINETOBACTER BAUMANNII; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLOOD GAS PARAMETERS; BREATHING RATE; CAUSE OF DEATH; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; DISEASE COURSE; DISEASE SEVERITY; DRUG UTILIZATION; DYSPNEA; FEMALE; FEVER; FRACTION OF INSPIRED OXYGEN; HOSPITAL INFECTION; HUMAN; HUMAN ADENOVIRUS C; IMMUNOCOMPROMIZED PATIENT; MALE; MORTALITY; OUTCOME ASSESSMENT; PARTIAL PRESSURE ARTERIAL OXYGEN; PLEURA EFFUSION; PNEUMONIA SEVERITY INDEX; RADIOGRAPHY; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SPRING; TREATMENT OUTCOME; VIRUS STRAIN; WINTER; ADENOVIRUS INFECTIONS, HUMAN; ADOLESCENT; CLINICAL TRIAL; COMMUNITY-ACQUIRED INFECTIONS; GENETICS; GENOTYPE; HOSPITAL; IMMUNOCOMPROMISED PATIENT; INTENSIVE CARE UNIT; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; PNEUMONIA, VIRAL; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; VIROLOGY; YOUNG ADULT;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADOLESCENT; ADULT; ANTIVIRAL AGENTS; CHINA; COMMUNITY-ACQUIRED INFECTIONS; DNA, VIRAL; FEMALE; GENOTYPE; HOSPITALS; HUMANS; IMMUNOCOMPROMISED HOST; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84962527390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151199     Document Type: Article

References (29)

1. Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, et al. Community-Acquired Pneumonia Requiring Hospitalization among U. S. Adults. N Engl J Med. 2015;373(5):415-27. Epub 2015/07/15. doi: 10.1056/NEJMoa1500245 PMID: 26172429.
2. Cao B, Huang GH, Pu ZH, Qu JX, Yu XM, Zhu Z, et al. Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest. 2014;145(1):79-86. Epub 2014/02/20. PMID: 24551881.
3. Lynch JP 3rd, Fishbein M, Echavarria M. Adenovirus. Semin RespirCritCare Med. 2011;32(4):494-511. doi: 10.1055/s-0031-1283287 PMID: 21858752.
4. Clark TW, Fleet DH, Wiselka MJ. Severe community-acquired adenovirus pneumonia in an immunocompetent 44-year-old woman: a case report and review of the literature. J Med Case Rep. 2011;5:259. doi: 10.1186/1752-1947-5-259 PMID: 21718493; PubMed Central PMCID: PMC3148995.
5. Lewis PF, Schmidt MA, Lu X, Erdman DD, Campbell M, Thomas A, et al. A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis. 2009;199(10):1427-34. doi: 10.1086/598521 PMID: 19351259.
6. Jones MS 2nd, Harrach B, Ganac RD, Gozum MM, Dela Cruz WP, Riedel B, et al. New adenovirus species found in a patient presenting with gastroenteritis. J Virol. 2007;81(11):5978-84. Epub 2007/03/16. doi: 10.1128/jvi.02650-06 PMID: 17360747; PubMed Central PMCID: PMCPMC1900323.
7. Chmielewicz B, Benzler J, Pauli G, Krause G, Bergmann F, Schweiger B. Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey. J Med Virol. 2005;77(2):232-7. Epub 2005/08/27. doi: 10.1002/jmv. 20441 PMID: 16121380.
8. Kajon AE, Dickson LM, Metzgar D, Houng HS, Lee V, Tan BH. Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP. J Clin Microbiol. 2010;48(4):1438-41. Epub 2010/02/05. doi: 10.1128/jcm.01928-09 PMID: 20129957; PubMed Central PMCID: PMCPMC2849553.
9. Kim SJ, Kim K, Park SB, Hong DJ, Jhun BW. Outcomes of early administration of cidofovirin nonimmunocompromised patients with severe adenovirus pneumonia. PLoSOne. 2015;10(4):e0122642. Epub 2015/04/16. doi: 10.1371/journal.pone.0122642 PMID: 25875735; PubMed Central PMCID: PMCPMC4398328.
10. Zhu Z, Zhang Y, Xu S, Yu P, Tian X, Wang L, et al. Outbreak of acute respiratory disease in China caused by B2 species of adenovirus type 11. J Clin Microbiol. 2009;47(3):697-703. Epub 2008/12/26. doi: 10.1128/jcm.01769-08 PMID: 19109466; PubMed Central PMCID: PMCPMC2650960.
11. Lu QB, Tong YG, Wo Y, Wang HY, Liu EM, Gray GC, et al. Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012. Influenza Other Respir Viruses. 2014;8(3):302-8. Epub 2014/01/29. doi: 10.1111/irv. 12232 PMID: 24467816; PubMed Central PMCID: PMCPMC4181478.
12. Jin Y, Zhang RF, Xie ZP, Yan KL, Gao HC, Song JR, et al. Prevalence of adenovirus in children with acute respiratory tract infection in Lanzhou, China. Virol J. 2013;10:271. Epub 2013/08/30. doi: 10. 1186/1743-422x-10-271 PMID: 23984826; PubMed Central PMCID: PMCPMC4015357.
13. Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, et al. Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med. 1998;158(4):1102-8. Epub 1998/10/14. doi: 10.1164/ajrccm.158.4.9803114 PMID: 9769267.
14. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336(4):243-50. Epub 1997/01/23. doi: 10.1056/nejm199701233360402 PMID: 8995086.
15. Guo L, Gonzalez R, Zhou H, Wu C, Vernet G, Wang Z, et al. Detection of three human adenovirus species in adults with acute respiratory infection in China. Eur J Clin Microbiol Infect Dis. 2012;31(6):1051-8. Epub 2011/10/04. doi: 10.1007/s10096-011-1406-8 PMID: 21964587.
16. Qu JX, Gu L, Pu ZH, Yu XM, Liu YM, Li R, et al. Viral etiology of community-acquired pneumonia among adolescents and adults with mild or moderate severity and its relation to age and severity. BMC Infect Dis. 2015;15:89. Epub 2015/03/27. doi: 10.1186/s12879-015-0808-0 PMID: 25812108; PubMed Central PMCID: PMCPMC4342096.
17. Gu L, Liu Z, Li X, Qu J, Guan W, Liu Y, et al. Severe community-acquired pneumonia caused by adenovirus type 11 in immunocompetent adults in Beijing. J Clin Virol. 2012;54(4):295-301. Epub 2012/05/23. doi: 10.1016/j.jcv. 2012.04.018 PMID: 22608839.
18. Sun B, He H, Wang Z, Qu J, Li X, Ban C, et al. Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study. Crit Care. 2014;18(4):456. Epub 2014/08/13. doi: 10.1186/s13054-014-0456-6 PMID: 25112957; PubMed Central PMCID: PMCPMC4243941.
19. Zhang SY, Luo YP, Huang DD, Fan H, Lu QB, Wo Y, et al. Fatal pneumonia cases caused by human adenovirus 55 in immunocompetent adults. Infect Dis (Lond). 2016;48(1):40-7. Epub 2015/10/16. doi: 10.3109/23744235.2015.1055585 PMID: 26465201.
20. Strauss R, Ewig S, Richter K, Konig T, Heller G, Bauer TT. The prognostic significance of respiratory rate in patients with pneumonia: a retrospective analysis of data from 705, 928 hospitalized patients in Germany from 2010-2012. Dtsch Arztebl Int. 2014;111(29-30):503-8, i-v. Epub 2014/08/22. doi: 10. 3238/arztebl.2014.0503 PMID: 25142073; PubMed Central PMCID: PMCPMC4150027.
21. Que YA, Virgini V, Lozeron ED, Paratte G, Prod'hom G, Revelly JP, et al. Low C-reactive protein values at admission predict mortality in patients with severe community-acquired pneumonia caused by Streptococcus pneumoniae that require intensive care management. Infection. 2015;43(2):193-9. Epub 2015/03/04. doi: 10.1007/s15010-015-0755-0 PMID: 25732200.
22. Lee JY, Lee JH, Kim DK, Yim JJ, Yoo CG, Chung HS, et al. C-reactive protein as a prognostic factor for mortality in pneumonia patients with liver cirrhosis. Hepatogastroenterology. 2014;61(133):1331-8. Epub 2014/12/17. PMID: 25513091.
23. Nie W, Zhang Y, Cheng J, Xiu Q. Corticosteroids in the treatment of community-acquired pneumonia in adults: a meta-analysis. PLoSOne. 2012;7(10):e47926. Epub 2012/11/01. doi: 10.1371/journal.pone. 0047926 PMID: 23112872; PubMed Central PMCID: PMCPMC3480455.
24. Siemieniuk RA, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, et al. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Metaanalysis. Ann Intern Med. 2015;163(7):519-28. Epub 2015/08/11. doi: 10.7326/m15-0715 PMID: 26258555.
25. Wan YD, Sun TW, Liu ZQ, Zhang SG, Wang LX, Kan QC. Efficacy and Safety of Corticosteroids for Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis. Chest. 2015. Epub2015/10/27. doi: 10.1378/chest.15-1733 PMID: 26501852.
26. van Woensel JB, Vyas H. Dexamethasone in children mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus: a randomized controlled trial. Crit Care Med. 2011;39(7):1779-83. Epub 2011/04/05. doi: 10.1097/CCM.0b013e318218a030 PMID: 21460709.
27. Brun-Buisson C, Richard JC, Mercat A, Thiebaut AC, Brochard L. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med. 2011;183(9):1200-6. Epub 2011/04/08. doi: 10.1164/rccm.201101-0135OC PMID: 21471082.
28. Park SY, Baek S, Lee SO, Choi SH, Kim YS, Woo JH, et al. Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores. Antimicrob Agents Chemother. 2013;57(2):983-9. Epub 2012/12/12. doi: 10.1128/aac.01961-12 PMID: 23229488; PubMed Central PMCID: PMCPMC3553680.
29. Takahashi I, Takahashi T, Tsuchida S, Mikami T, Saito H, Hatazawa C, et al. Pulse methylprednisolone therapy in type 3 adenovirus pneumonia with hypercytokinemia. Tohoku J Exp Med. 2006;209(1):69-73. Epub 2006/04/26. PMID: 16636525.